$175 Million is the total value of Forefront Analytics, LLC's 115 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 4.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ESGD | Buy | ISHARES TResg aw msci eafe | $25,636,392 | +30.6% | 351,518 | +28.6% | 14.62% | +44.4% |
| VEA | Buy | VANGUARD TAX-MANAGED FDSvan ftse dev mkt | $12,448,545 | +3.2% | 269,566 | +0.9% | 7.10% | +14.2% |
| SPY | Buy | SPDR S&P 500 ETF TRtr unit | $8,759,699 | +8.7% | 19,761 | +0.4% | 5.00% | +20.2% |
| VB | Buy | VANGUARD INDEX FDSsmall cp etf | $2,259,687 | +5.3% | 11,361 | +0.4% | 1.29% | +16.5% |
| STIP | Buy | ISHARES TR0-5 yr tips etf | $2,090,197 | -1.5% | 21,416 | +0.2% | 1.19% | +9.0% |
| FLRN | Buy | SPDR SER TRbloomberg invt | $1,864,380 | +1.7% | 60,749 | +0.9% | 1.06% | +12.6% |
| SHV | Buy | ISHARES TRshort treas bd | $1,334,227 | +0.5% | 12,080 | +0.6% | 0.76% | +11.3% |
| FLOT | Buy | ISHARES TRfltg rate nt etf | $1,039,324 | +2.3% | 20,451 | +1.4% | 0.59% | +13.2% |
| XLRE | Buy | SELECT SECTOR SPDR TRrl est sel sec | $1,037,835 | +1.8% | 27,537 | +1.0% | 0.59% | +12.8% |
| JPM | Buy | JPMORGAN CHASE & CO | $501,820 | +12.8% | 3,450 | +1.1% | 0.29% | +24.9% |
| SCHA | Buy | SCHWAB STRATEGIC TRus sml cap etf | $451,480 | +4.8% | 10,308 | +0.4% | 0.26% | +16.2% |
| DE | Buy | DEERE & CO | $444,883 | -1.2% | 1,098 | +0.7% | 0.25% | +9.5% |
| VWOB | Buy | VANGUARD WHITEHALL FDSem mk gov bd etf | $377,576 | +0.8% | 6,064 | +0.9% | 0.22% | +11.4% |
| REET | Buy | ISHARES TRglobal reit etf | $340,596 | +0.7% | 14,828 | +0.6% | 0.19% | +11.5% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $303,910 | +19.6% | 630 | +17.5% | 0.17% | +32.1% |
| PFE | Buy | PFIZER INC | $283,803 | +14.5% | 7,735 | +27.3% | 0.16% | +26.6% |
| ESGE | Buy | ISHARES INCesg awr msci em | $262,542 | +0.5% | 8,300 | +0.1% | 0.15% | +11.1% |
| INCY | Buy | INCYTE CORP | $219,931 | -13.7% | 3,533 | +0.2% | 0.12% | -4.6% |
| ANNX | Buy | ANNEXON INC | $94,302 | +60.6% | 26,790 | +75.7% | 0.05% | +80.0% |
| Buy | JASPER THERAPEUTICS INC | $95,034 | +73.3% | 69,367 | +129.0% | 0.05% | +92.9% | |
| FUSN | New | FUSION PHARMACEUTICALS INC | $93,753 | – | 20,075 | +100.0% | 0.05% | – |
| CTMX | Buy | CYTOMX THERAPEUTICS INC | $85,306 | +113.9% | 49,596 | +87.8% | 0.05% | +133.3% |
| PSTX | Buy | POSEIDA THERAPEUTICS INC | $46,850 | +1.1% | 26,619 | +77.0% | 0.03% | +12.5% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- GKFO LLC #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| PIMCO ETF TR | 24 | Q3 2023 | 7.9% |
| SPDR S&P 500 ETF TR | 24 | Q3 2023 | 10.6% |
| VANGUARD TAX-MANAGED INTL FD | 24 | Q3 2023 | 7.6% |
| DBX ETF TR | 24 | Q3 2023 | 6.0% |
| VANGUARD WORLD FD | 24 | Q3 2023 | 8.0% |
| ISHARES TR | 24 | Q3 2023 | 6.2% |
| ISHARES TR | 24 | Q3 2023 | 5.8% |
| FIRST TR EXCHANGE-TRADED FD | 24 | Q3 2023 | 6.3% |
| ISHARES TR | 24 | Q3 2023 | 5.8% |
| ISHARES INC | 24 | Q3 2023 | 6.0% |
View Forefront Analytics, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-08 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-10 |
| 13F-HR | 2022-05-09 |
| 13F-HR | 2022-02-11 |
View Forefront Analytics, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.